Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties

Annamária Cseh; Jacques-Emmanuel Galimard; Josu De La Fuente; Antonella Isgro; Marco Zecca; Birgit Garwer; Alexandra Biffi; Mahmoud Aljurf; Mikael Sundin; Cristina Belendez; Franco Locatelli; Adriana Balduzzi; Sarah Lawson; Henrik Sengeloev; Marianne Ifversen; Riccardo Saccardi; Robert Wynn; Arjan C. Lankester; Selim Corbacioglu; Christina Peters

doi:10.1111/bjh.19122

Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties

Annamária Cseh, Jacques-Emmanuel Galimard, Josu De La Fuente, Antonella Isgro, Marco Zecca, Birgit Garwer, Alexandra Biffi, Mahmoud Aljurf, Mikael Sundin, Cristina Belendez, Franco Locatelli, Adriana Balduzzi, Sarah Lawson, Henrik Sengeloev, Marianne Ifversen, Riccardo Saccardi, Robert Wynn, Arjan C. Lankester, Selim Corbacioglu, Christina Peters

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1-5
Number of pages	5
Journal	British Journal of Haematology
DOIs	https://doi.org/10.1111/bjh.19122
Publication status	Published - 2023

Keywords

HSCT
sickle cell disease

Access to Document

10.1111/bjh.19122

Cite this

Cseh, A., Galimard, J.-E., De La Fuente, J., Isgro, A., Zecca, M., Garwer, B., Biffi, A., Aljurf, M., Sundin, M., Belendez, C., Locatelli, F., Balduzzi, A., Lawson, S., Sengeloev, H., Ifversen, M., Saccardi, R., Wynn, R., Lankester, A. C., Corbacioglu, S., & Peters, C. (2023). Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties. British Journal of Haematology, 1-5. https://doi.org/10.1111/bjh.19122

Cseh, Annamária ; Galimard, Jacques-Emmanuel ; De La Fuente, Josu et al. / Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties. In: British Journal of Haematology. 2023 ; pp. 1-5.

@article{62c375d22f014c54b4b4c74eb28a251b,

title = "Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties",

keywords = "HSCT, sickle cell disease, HSCT, sickle cell disease",

author = "Annam{\'a}ria Cseh and Jacques-Emmanuel Galimard and {De La Fuente}, Josu and Antonella Isgro and Marco Zecca and Birgit Garwer and Alexandra Biffi and Mahmoud Aljurf and Mikael Sundin and Cristina Belendez and Franco Locatelli and Adriana Balduzzi and Sarah Lawson and Henrik Sengeloev and Marianne Ifversen and Riccardo Saccardi and Robert Wynn and Lankester, {Arjan C.} and Selim Corbacioglu and Christina Peters",

year = "2023",

doi = "10.1111/bjh.19122",

language = "English",

pages = "1--5",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

}

Cseh, A, Galimard, J-E, De La Fuente, J, Isgro, A, Zecca, M, Garwer, B, Biffi, A, Aljurf, M, Sundin, M, Belendez, C, Locatelli, F, Balduzzi, A, Lawson, S, Sengeloev, H, Ifversen, M, Saccardi, R, Wynn, R, Lankester, AC, Corbacioglu, S & Peters, C 2023, 'Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties', British Journal of Haematology, pp. 1-5. https://doi.org/10.1111/bjh.19122

Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties. / Cseh, Annamária; Galimard, Jacques-Emmanuel; De La Fuente, Josu et al.
In: British Journal of Haematology, 2023, p. 1-5.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties

AU - Cseh, Annamária

AU - Galimard, Jacques-Emmanuel

AU - De La Fuente, Josu

AU - Isgro, Antonella

AU - Zecca, Marco

AU - Garwer, Birgit

AU - Biffi, Alexandra

AU - Aljurf, Mahmoud

AU - Sundin, Mikael

AU - Belendez, Cristina

AU - Locatelli, Franco

AU - Balduzzi, Adriana

AU - Lawson, Sarah

AU - Sengeloev, Henrik

AU - Ifversen, Marianne

AU - Saccardi, Riccardo

AU - Wynn, Robert

AU - Lankester, Arjan C.

AU - Corbacioglu, Selim

AU - Peters, Christina

PY - 2023

Y1 - 2023

KW - HSCT

KW - sickle cell disease

KW - HSCT

KW - sickle cell disease

UR - http://hdl.handle.net/10807/276677

U2 - 10.1111/bjh.19122

DO - 10.1111/bjh.19122

M3 - Article

SN - 0007-1048

SP - 1

EP - 5

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -

Cseh A, Galimard JE, De La Fuente J, Isgro A, Zecca M, Garwer B et al. Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties. British Journal of Haematology. 2023;1-5. doi: 10.1111/bjh.19122

Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties

Keywords

Access to Document

Other files and links

Cite this